Zealand Pharma A/S (CPH:ZEAL)
463.20
-2.20 (-0.47%)
Apr 3, 2025, 4:59 PM CET
Zealand Pharma Employees
Zealand Pharma had 335 employees as of December 31, 2024. The number of employees increased by 82 or 32.41% compared to the previous year.
Employees
335
Change (1Y)
82
Growth (1Y)
32.41%
Revenue / Employee
187.14K DKK
Profits / Employee
-3.22M DKK
Market Cap
32.73B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Novo Nordisk | 77,349 |
Coloplast | 16,639 |
Genmab | 2,682 |
Demant | 22,639 |
H. Lundbeck | 5,707 |
Ambu A/S | 5,196 |
ALK-Abelló | 2,753 |
GN Store Nord | 7,347 |
Zealand Pharma News
- 7 days ago - Resolutions from Zealand Pharma's Annual General Meeting 2025 - GlobeNewsWire
- 9 days ago - Zealand Pharma major shareholder announcement: Van Herk Investments B.V. - GlobeNewsWire
- 14 days ago - Zealand Pharma increases its share capital as a result of the exercise of employee warrants - GlobeNewsWire
- 17 days ago - Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity - GlobeNewsWire
- 22 days ago - Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal - The Wall Street Journal
- 22 days ago - Roche agrees biggest-ever obesity drug deal - Financial Times
- 22 days ago - Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion - Investor's Business Daily
- 22 days ago - Roche And Zealand Team Up To Develop Petrelintide - Seeking Alpha